Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | FAAH | O00519 | 6/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | RARB | P10826 | 3/20 | 0.38 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2437074 | 0.92 | TSHR (0.44) | LTA4HTSHRTP53PLA2G4BCA12 | |
| SCHEMBL2436260 | 0.90 | TSHR (0.44) | LTA4HTSHRTP53PLA2G4BCA12 | |
| Trifluoromethanesulfonic Acid SCHEMBL4619536 | 0.89 | LTA4H (0.48) | LTA4HTSHRTP53PLA2G4BCA12 | |
| Trifluoromethanesulfonic Acid SCHEMBL4618163 | 0.89 | LTA4H (0.48) | LTA4HTSHRTP53PLA2G4BCA12 | |
| Trifluoromethanesulfonic Acid SCHEMBL4606074 | 0.89 | LTA4H (0.48) | LTA4HTSHRTP53PLA2G4BCA12 | |
| SCHEMBL29745975 | 0.87 | TSHR (0.47) | LTA4HTSHRTP53PLA2G4BCA12 | |
| SCHEMBL2437076 | 0.87 | NR5A1 (0.42) | TSHRTP53PLA2G4BCA12CA1 | |
| SCHEMBL2436263 | 0.84 | NR5A1 (0.42) | TSHRTP53PLA2G4BCA12CA1 | |
| SCHEMBL2437727 | 0.84 | TSHR (0.41) | TSHRTP53PLA2G4BCA12CA1 | |
| Trifluoromethanesulfonic Acid SCHEMBL4618765 | 0.84 | TSHR (0.48) | LTA4HTSHRTP53PLA2G4BCA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7601480-B2 | Photoactive compounds | AZ ELECTRONIC MATERIALS USA CORP. (US) | 2009-10-13 | — | — | US | disclosed |
| EP-1943287-A2 | MOLDING COMPOSITION AND METHOD, AND MOLDED ARTICLE | General Electric Company (US) | 2008-07-16 | — | — | EP | disclosed |
| US-20080153032-A1 | Photoactive Compounds | MERCK PATENT GMBH (DE) | 2008-06-26 | — | — | US | disclosed |
| US-7378455-B2 | A curable epoxy resin , two latent cationic curing catalyst, a free radical-producng cocatalyst and inorganic filler of about 70-95 weight % based on the total weight; catalyst allows the use of increased filler loadingsto reduce moisture absorption and thermal expansion; encapsulating solid state device | GENERAL ELECTRIC COMPANY (US) | 2008-05-27 | — | — | US | disclosed |
| WO-2007005280-A2 | MOLDING COMPOSITION AND METHOD, AND MOLDED ARTICLE | GENERAL ELECTRIC COMPANY (US) | 2007-01-11 | — | — | WO | disclosed |
| US-20070004819-A1 | A curable epoxy resin , two latent cationic curing catalyst, a free radical-producng cocatalyst and inorganic filler of about 70-95 weight % based on the total weight; catalyst allows the use of increased filler loadingsto reduce moisture absorption and thermal expansion; encapsulating solid state device | CITIBANK, N.A., AS COLLATERAL AGENT | 2007-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080153032-A1 | Photoactive Compounds | SUN2, CRY2, SCO2 | LTA4H 1170/4885TSHR 4095/4885TP53 4141/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.